The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Mirena IUD Brain Injury Action Denied MDL Transfer

Posted on November 17, 2015 by Larry Bodine

Mirena IUDA United States Judicial Panel on Multidistrict Litigation (MDL) has denied the transfer of nine pending actions against intrauterine device (IUD) maker Bayer Healthcare Pharmaceuticals, Inc. (Bayer).

The nine actions that are pending in six districts assert that the synthetic hormone, levonorgestrel, released by the Mirena IUD results in a neurological condition called pseudotumor cerebri or idiopathic intracranial hypertension.

Progesterone hormone released

Levonorgestrel is a type of progesterone hormone that prevents pregnancy by thickening a woman’s cervical mucus, creating an impenetrable barrier for sperm.  It also restricts uterine lining thickness, which affects fertilization and prevents pregnancy.

Intracranial hypertension causes abnormal elevation of cerebrospinal fluid in the skull which may cause symptoms of severe migraine headaches, tinnitis (ringing in the ears), vision loss, swollen optic nerves and possible blindness. In severe cases, placement of a shunt to drain the fluid in the skull is recommended, according to a memorandum in support of the transfer to an MDL court.

Centralization not warranted

The judicial panel discussed that some characteristics of the litigation would benefit from centralization in an MDL docket, but ultimately found that centralization was not warranted.  The nine actions share factual issues arising from the synthetic hormone released by the Mirena IUD, and charge that Bayer failed to warn consumers of the risks associated with its use.

However, the court was unconvinced that centralization was necessary for convenience and efficient litigation in the matter because a single plaintiffs’ counsel filed all nine actions naming Bayer as the defendant in each.  Bayer has national counsel coordinating its response to the litigation and is willing to share any overlapping discovery.

The court stated, “given the few involved counsel and limited number of actions, informal cooperation among the involved attorneys is both practicable and preferable to centralization.

Unlike pending Mirena MDL litigation

The court agreed with Bayer’s assertion that unlike the MDL No. 2434 litigation involving Mirena IUD for uterine perforation and migration injuries, the neurological symptoms alleged in this case are nonspecific and would require “fact-intensive inquiry over whether each plaintiff was properly diagnosed.”

See also: Mirena IUD’s Harmful Side Effects Lead to Multidistrict Litigation

The plaintiffs also acknowledged that the symptoms of intracranial hypertension at issue in this case are also regularly diagnosed in individuals who do not use Mirena.

The court lastly found that the mere possibility of six additional related actions still did not warrant centralization and denied the plaintiff’s motion to transfer the case to an MDL court.

 

The case is In RE: Mirena IUS Levonorgestrel-Related Products Liability Litigation, Case MDL number 2559 in the United States Judicial Panel on Multidistrict Litigation.

Posted in Blog, Consumer Protection, Medical Malpractice, Product Liability

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

The U.S. Department of Justice and U.S. Environmental Protection Agency (EPA) announced today that the United States has[Read More...]
Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Bingen, Wash.-based Insitu, a Boeing subsidiary, has agreed to pay $25 million to settle allegations that it used recycl[Read More...]
Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

DEUTSCHE Bank AG agreed to pay US$130 million to settle criminal and civil charges that it bribed foreign officials and manip[Read More...]
Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing has agreed to pay just over $2.5 billion to resolve a federal charge of “criminal misconduct” for how its [Read More...]
Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

The mass exodus of Texas Attorney General Ken Paxton's top staff over accusations of bribery against their former boss has le[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.